164 related articles for article (PubMed ID: 32258949)
1. Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.
Jin D; Lu T; Ni M; Wang H; Zhang J; Zhong C; Shen C; Hao J; Busuttil RW; Kupiec-Weglinski JW; Zhang J; Xu N; Zhai Y
Hepatol Commun; 2020 Apr; 4(4):540-554. PubMed ID: 32258949
[TBL] [Abstract][Full Text] [Related]
2. GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.
Zhang S; Pan X; Jeong H
Drug Metab Dispos; 2015 May; 43(5):743-8. PubMed ID: 25725071
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation.
Zhou H; Wang H; Ni M; Yue S; Xia Y; Busuttil RW; Kupiec-Weglinski JW; Lu L; Wang X; Zhai Y
J Hepatol; 2018 Jul; 69(1):99-109. PubMed ID: 29452207
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.
Pan X; Lee YK; Jeong H
Drug Metab Dispos; 2015 Jul; 43(7):1002-7. PubMed ID: 25926433
[TBL] [Abstract][Full Text] [Related]
5. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
Li G; Kong B; Zhu Y; Zhan L; Williams JA; Tawfik O; Kassel KM; Luyendyk JP; Wang L; Guo GL
Toxicol Appl Pharmacol; 2013 Oct; 272(2):299-305. PubMed ID: 23811326
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
7. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
Li G; L Guo G
Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
[TBL] [Abstract][Full Text] [Related]
9. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
10. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
11. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
12. Activation of FXR pathway does not alter glial cell function.
Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
[TBL] [Abstract][Full Text] [Related]
13. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
15. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
16. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity.
Jin J; Sun X; Zhao Z; Wang W; Qiu Y; Fu X; Huang M; Huang Z
Phytomedicine; 2015 Sep; 22(10):894-901. PubMed ID: 26321738
[TBL] [Abstract][Full Text] [Related]
17. Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2.
Zhou H; Ni Z; Li T; Su L; Zhang L; Liu N; Shi Y
Oncol Lett; 2018 May; 15(5):7617-7624. PubMed ID: 29849798
[TBL] [Abstract][Full Text] [Related]
18. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor agonist GW4064 ameliorates lipopolysaccharide-induced ileocolitis through TLR4/MyD88 pathway related mitochondrial dysfunction in mice.
Liu HM; Liao JF; Lee TY
Biochem Biophys Res Commun; 2017 Aug; 490(3):841-848. PubMed ID: 28647362
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic pretreatment attenuates liver ischemia-reperfusion injury by Farnesoid X receptor activation.
Liu H; Wang J; Ding Y; Shi X; Ren H
Cell Death Dis; 2022 May; 13(5):484. PubMed ID: 35597796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
